The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma

To Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma Clinical Trial

Official title: The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma

Status Not yet recruiting

Clinical Trial Summary

1. Compare the efficacy of R-EPOCH and R-CHOP regimen for patients with AIDS associated CD20+ diffuse large B lymphoma; 2. Compare the safety of R-EPOCH and R-CHOP regimen for patients with AIDS associated CD20+ diffuse large B lymphoma.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Lymphoma
• To Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma

• NCT number: NCT03045471
• Study type: Observational
• Source: Shanghai Public Health Clinical Center
• Contact: Hongzhou Lu, PhD
• Phone: +8618930810088
• Email: luhongzhou@fudan.edu.cn
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 1, 2017
• Completion date: December 31, 2021